GRAIL, Inc.

GRAL · Healthcare

$80.34

Markedsværdi: 3.59B USDUdbytteafkast: —
AdvancedEr det et godt tidspunkt at købe GRAIL, Inc.? Spørg Copenvest AIFå et Advanced AI-bud på timing, risiko og hvad tracked investorer gør.Spørg Copenvest AI

Indlæser diagram…

Nyheder

Seneste overskrifter for denne aktie

Motley Fool4. sep. 2026, 12.10

Grail Stock Jumps in August as FDA Schedules a Key Meeting for its Galleri Cancer Test

PR Newswire3. sep. 2026, 20.02

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire31. aug. 2026, 20.01

GRAIL to Present at Morgan Stanley's 24th Annual Global Healthcare Conference

MarketBeat14. aug. 2026, 07.04

GRAIL Highlights Galleri Growth Ahead of Key FDA Advisory Meeting